glp-1 max for diabetes Chart: 1 in 8 Americans Now Use Drugs Weight Loss Key Facts GPs Should Know
Description
Pros: Long track record of safety
Track daily symptoms Takes 10 seconds a day
The SUSTAIN-7 trial was a randomized, open-label, active-controlled, parallel, four-armed trial
doi:10.1016/j.pcl.2009.07.002
These benefits were consistent regardless of baseline diabetes [47] or glycemic status [52]
